- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04319289
Effect of Aerobic Interval Training With Vitamin D Supplement on Functional Capacity and Perceived Myalgia
Effect of Aerobic Interval Training Combined With Vitamin D Supplement on Functional Capacity and Perceived Myalgia in Middle Aged Obese Women
Study Overview
Status
Conditions
Detailed Description
Forty five women complaining from myalgia with vitamin D deficiency participating in this study. Their ages are ranged from 30 to 40 years.
They are assigned randomly into three groups:
- Group (A): included 15 patients who are participating in an aerobic interval training exercise program with vitamin D supplementation (cholecalciferol 400 IU/day).
- Group (B): included 15 patients who are receiving vitamin D supplementation only (cholecalciferol 400 IU/day).
- Group (C): included 15 patients who are participating in an interval training exercise program only.
The intervention will last for 12 weeks
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt, 12316
- Faculty of Physical Therapy
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Forty five sedentry women with non specific myalgia pain.
- The patients' ages ranged from 30 -40 years.
- All patients have non specific muscle pain for more than 2 months.
- They have vitamin D deficiency.
- All patients have BMI from 25 to 34.9 kg/m2.
- All patients were clinically and medically stable when attending the study.
Exclusion Criteria:
- Unstable cardiovascular and chest problems.
- Patients with diseases which affect vitamin D level as a history of rheumatic or metabolic bone diseases and diabetes.
- Patients taking drugs which affect vitamin D level as steroids and anticonvulsants drugs .
- Musculoskeletal disorders which may affect their physical ability to do the exercises.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group (A)
Included 15 patients who are participating in an aerobic interval training exercise program with vitamin D supplementation (cholecalciferol 400 IU/day). The aerobic interval training is conducted for one hour, three days per week on a total period of 12 weeks. |
The participants in both groups A will be instructed to perform aerobic interval exercises at 70% maxHR for 5 minutes and then decrease activity to 50% for 5 minutes and repeat for the length of the activity (the training will be done by using bicycle ergometer(Biodex LBC, Biodex Inc., New York).• Before starting training ; Maximum heart rate calculated from the following equation: maxHR= 220-age .
Also all participants in this group are taking gne capsule containing (cholecalciferol 400 IU) every day . |
|
Experimental: Group (B)
Included 15 patients who are receiving vitamin D supplementation only .
One capsule containing (cholecalciferol 400 IU) was taken every day for 12 weeks
|
One capsule containing (cholecalciferol 400 IU) was taken every day .
|
|
Experimental: Group (c)
Included 15 patients who are participating in an aerobic interval training exercise program only.
The aerobic interval training is conducted for one hour, three days per week on a total period of 12 weeks.
|
The participants in group C will be instructed to perform aerobic interval exercises at 70% maxHR for 5 minutes and then decrease activity to 50% for 5 minutes and repeat for the length of the activity (the training will be done by using bicycle ergometer(Biodex LBC, Biodex Inc., New York).• Before starting training ; Maximum heart rate calculated from the following equation: maxHR= 220-age (Gellish ,2007).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Concentration of Plasma Serum vitamin D level (25OHD)
Time Frame: It is performed before and after the study(12 weeks interval) for all groups
|
It is performed by Laboratory BioPlex® 2200 System
|
It is performed before and after the study(12 weeks interval) for all groups
|
|
Description of Functional capacity efficiency
Time Frame: It is performed before and after the study(12 weeks interval) for all groups
|
Cooper 12-Minute Walk Test (12MWT)
|
It is performed before and after the study(12 weeks interval) for all groups
|
|
Intensity of non specific muscle pain (myalgia)
Time Frame: It is performed before and after the study(12 weeks interval) for all groups
|
A 10-cm Visual Analogue Scale (VAS) was used to evaluate the patients' pain , with 0 representing no pain and 10 representing the worst pain imaginable
|
It is performed before and after the study(12 weeks interval) for all groups
|
|
Description of the improvement in Quality of life
Time Frame: It is performed before and after the study(12 weeks interval) for all groups
|
The Short form health survey (SF-12)is often used to compare health status between groups of patients, to indentify predictors of health status
|
It is performed before and after the study(12 weeks interval) for all groups
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Nervous System Diseases
- Pain
- Neurologic Manifestations
- Nutrition Disorders
- Musculoskeletal Diseases
- Muscular Diseases
- Neuromuscular Diseases
- Musculoskeletal Pain
- Avitaminosis
- Deficiency Diseases
- Malnutrition
- Myalgia
- Vitamin D Deficiency
- Physiological Effects of Drugs
- Micronutrients
- Bone Density Conservation Agents
- Calcium-Regulating Hormones and Agents
- Vitamin D
- Cholecalciferol
- Vitamins
- Ergocalciferols
Other Study ID Numbers
- 2020HAAE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitamin D Deficiency
-
University Hospital, Clermont-FerrandTerminated
-
Rajavithi HospitalQueen Sirikit National Institute of Child HealthCompleted
-
Universidade de Passo FundoUnknownDeficiency, Vitamin DBrazil
-
Nutrition Institute, SloveniaEuropean Regional Development Fund; Vizera d.o.o.; Frutarom Etol d.o.o.CompletedVitamin B 12 Deficiency | Vitamin d Deficiency | Protein DeficiencySlovenia
-
Federal University of Rio Grande do SulCompletedDeficiency, Vitamin DBrazil
-
University of PaviaIstituti Clinici Scientifici Maugeri SpAUnknownVitamin D Deficiency | Vitamin D3 Deficiency | Vitamin DItaly
-
Wageningen UniversityDSM Nutritional Products, Inc.; Top Institute Food and NutritionCompletedElderly, Frail | Deficiency, Vitamin DNetherlands
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingVitamin d DeficiencyChina
-
University of DelawareCompleted
-
University of Missouri, Kansas CityTruman Medical CenterWithdrawnVitamin d DeficiencyUnited States
Clinical Trials on aerobic interval training and Vitamin D supplementation,
-
Riphah International UniversityCompletedMyocardial InfarctionPakistan
-
General Hospital Murska SobotaUniversity of Primorska; University of LjubljanaUnknownCoronary Artery Disease | Heart Failure With Reduced Ejection FractionSlovenia
-
Kuopio Research Institute of Exercise MedicineKuopio University Hospital; University of Basel; University of Eastern Finland; Social Insurance Institution, FinlandTerminatedUnstable Angina Pectoris | Acute Myocardial Infarction | Recurrent Myocardial InfarctionFinland
-
Norwegian University of Science and TechnologyUniversity of Sao Paulo; Helse Stavanger HF; Technical University of Munich; The... and other collaboratorsCompletedMetabolic SyndromeNorway, Brazil, Australia, Ecuador, Germany
-
St. Olavs HospitalNorwegian University of Science and TechnologyCompletedTachycardia, Ventricular | Defibrillators, ImplantableNorway
-
Riphah International UniversityCompletedCoronary Artery DiseasePakistan
-
Norwegian University of Science and TechnologyCompletedHealthy SubjectsNorway
-
Cairo UniversityCompleted
-
Riphah International UniversityCompletedCoronary Artery DiseasePakistan
-
Norwegian University of Science and TechnologyCompleted